foxo4-dri senolytic 2024 animal model regulates endothelial cell senescence via the P53 signaling pathway FOXO4‐DRI improves the impaired ratio
FOXO4DRI improves the impaired ratio of lung cells. The BLMinduced PF Download Scientific Diagram Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



